Edition:
United Kingdom

Xenetic Biosciences Inc (XBIO.OQ)

XBIO.OQ on NASDAQ Stock Exchange Capital Market

2.38USD
17 Oct 2018
Change (% chg)

$0.05 (+2.15%)
Prev Close
$2.33
Open
$2.38
Day's High
$2.40
Day's Low
$2.38
Volume
2,714
Avg. Vol
129,295
52-wk High
$8.94
52-wk Low
$1.45

Chart for

About

Xenetic Biosciences, Inc. is a clinical-stage biopharmaceutical company. The Company focuses on discovery, research and development of biologic drugs and novel oncology therapeutics. The Company’s lead investigational product candidate is oncology therapeutic XBIO-101, which is used for the treatment of progestin - resistant... (more)
No analyst recommendations are available for .

Overall

Beta: 1.30
Market Cap(Mil.): $25.89
Shares Outstanding(Mil.): 8.72
Dividend: --
Yield (%): --

Financials

  XBIO.OQ Industry Sector
P/E (TTM): -- 85.92 33.73
EPS (TTM): -1.48 -- --
ROI: -72.68 0.63 14.31
ROE: -141.57 1.68 16.04

Competitors

  Price Chg
Actelion Ltd (ATLN.S) -- --
Incyte Corporation (INCY.OQ) $65.04 +0.13

Earnings vs. Estimates